Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
The brains of Alzheimer’s disease (AD) patients are characterized by deposits of Abeta peptides and by accompanying chronic inflammation. Here, we provide evidence that the enzyme isoglutaminyl cyclase (isoQC) is a novel factor contributing to both aspects of AD pathology. Two putative substrates of...
Main Authors: | Hartlage-Rübsamen, Maike, Waniek, Alexander, Meißner, Juliane, Morawski, Markus, Schilling, Stephan, Jäger, Carsten, Kleinschmidt, Martin, Cynis, Holger, Kehlen, Astrid, Arendt, Thomas, Demuth, Hans-Ulrich, Roßner, Steffen |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer Berlin Heidelberg
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366547/ |
Similar Items
-
Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms
by: Hartlage-Rübsamen, Maike, et al.
Published: (2011) -
The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions
by: Cynis, Holger, et al.
Published: (2011) -
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
by: Becker, Andreas, et al.
Published: (2013) -
Effect of brevican deficiency on neuroplasticity mediating molecules
by: Weigel, Solveig, et al.
Published: (2015) -
CCL2 Disrupts the Adherens Junction: Implications for Neuroinflammation
by: Roberts, Toni K., et al.
Published: (2012)